{"company": {"org_id": "Q000ACEA4E", "org_name_cn": "迈威(上海)生物科技股份有限公司", "org_short_name_cn": "迈威生物", "org_name_en": "Mabwell(Shanghai)Bioscience Co.,Ltd.", "org_short_name_en": "Mabwell", "main_operation_business": "治疗用生物制品的研发、生产与销售。", "operating_scope": "　　从事生物科技领域内的技术开发、技术咨询、技术服务、技术转让，技术推广服务，自有设备租赁，从事货物及技术的进出口业务。【依法须经批准的项目，经相关部门批准后方可开展经营活动】", "district_encode": "310115", "org_cn_introduction": "迈威(上海)生物科技股份有限公司的主营业务是治疗用生物制品的研发、生产与销售。公司的主要产品是抗体药物、抗体药物、技术服务。公司拥有79件已授权发明专利，其中47件为中国专利，32件为国家专利，独立承担1项国家“重大新药创制”重大科技专项，独立/牵头承担共计2项国家重点研发计划和多项省市级科技创新项目。", "legal_representative": "刘大涛", "general_manager": "刘大涛", "secretary": "胡会国", "established_date": 1494518400000, "reg_asset": 399600000.0, "staff_num": 1416, "telephone": "86-21-58332260", "postcode": "201210", "fax": "86-21-58585793-6520", "email": "ir@mabwell.com", "org_website": "www.mabwell.com", "reg_address_cn": "上海市浦东新区中国(上海)自由贸易试验区蔡伦路230号2幢105室", "reg_address_en": null, "office_address_cn": "上海市浦东新区中国(上海)自由贸易试验区蔡伦路230号2幢105室", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1642435200000, "provincial_name": "上海市", "actual_controller": "唐春山 (28.32%)，陈姗娜 (7.03%)", "classi_name": "外资企业", "pre_name_cn": "迈威(上海)生物科技有限公司", "chairman": "刘大涛", "executives_nums": 18, "actual_issue_vol": 99900000.0, "issue_price": 34.8, "actual_rc_net_amt": 3303432172.0, "pe_after_issuing": null, "online_success_rate_of_issue": 0.03592675, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}}